体育与实时比分
Harbaugh offers rare critique of struggling QB Herbert: 'Be better'
来源: espn.com · 发布于
Chargers coach Jim Harbaugh offered a rare public critique of Justin Herbert on Monday, imploring the quarterback to "be better."
Chargers coach Jim Harbaugh offered a rare public critique of Justin Herbert on Monday, imploring the quarterback to "be better."
相关报道
Yankees' Judge takes BP as push to play vs. Red Sox continues
Aaron Judge participated in batting practice on the field Monday for the first time since suffering a right calf strain Sept. 16, as he works to persuade the team's decision-makers to put him on their wild-card series roster against the Boston Red Sox.
espn.com ·
Poch: No punishment for Man City can repair severe damage done
United States manager, Mauricio Pochettino said Monday that it was "very difficult" to know what punishment Manchester City should receive for breaking the Premier League's financial fair play rules -- and severely damaging the competition.
espn.com ·
Boeing "incredibly excited" to serve as nation's only astronaut transportation
NASA announced on Monday that it will exercise options to purchase two additional flights on Boeing's Starliner spacecraft, as well as financially support the company in its efforts to return the crewed vehicle to flight and find a new rocket after the Atlas V vehicle retires. Th
Ars Technica - All content ·
Florida invokes extinction fears in legal bid to halt OpenAI development
The state of Florida is seeking a temporary injunction to stop OpenAI from continuing to develop what it calls a "reckless, unacceptably risky product" without the deployment of "third-party approved safety guardrails." The new legal motion , filed Monday morning, is part of a ci
Ars Technica - All content ·
To keep drug prices high, pharma has been piling up the patents
The cost of healthcare in general is a debilitating, pre-existing condition for Americans. But the high prices of prescription drugs usually stand out as a pain point. While there are many insidious reasons why Americans pay more—often far more—for their medicines than people in
Ars Technica - All content ·